{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T10:23:08Z","timestamp":1763893388213,"version":"3.45.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,23]]},"DOI":"10.7759\/cureus.97541","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T10:05:58Z","timestamp":1763892358000},"source":"Crossref","is-referenced-by-count":0,"title":["Pathogenic MAX Variant in Bilateral Adrenal Paragangliomas: The Dilemma of Cortical-Sparing Surgery"],"prefix":"10.7759","author":[{"given":"Henrique","family":"Carmona Alexandrino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreia","family":"Martins Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Godinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00e9mia","family":"Castelo Branco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete O","year":"2022","unstructured":"Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A. Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas. Endocr Pathol. 2022, 33:90-114. 10.1007\/s12022-022-09704-6","journal-title":"Endocr Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac105","article-title":"Systematic review: incidence of pheochromocytoma and paraganglioma over 70 years","volume":"6","author":"Al Subhi AR","year":"2022","unstructured":"Al Subhi AR, Boyle V, Elston MS. Systematic review: incidence of pheochromocytoma and paraganglioma over 70 years. J Endocr Soc. 2022, 6:105. 10.1210\/jendso\/bvac105","journal-title":"J Endocr Soc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.14744\/SEMB.2020.18794","article-title":"Pheochromocytoma and paraganglioma: from epidemiology to clinical findings","volume":"54","author":"Aygun N","year":"2020","unstructured":"Aygun N, Uludag M. Pheochromocytoma and paraganglioma: from epidemiology to clinical findings. Sisli Etfal Hastan Tip Bul. 2020, 54:159-68. 10.14744\/SEMB.2020.18794","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030594","article-title":"New insights on the genetics of pheochromocytoma and paraganglioma and its clinical implications","volume":"14","author":"Jhawar S","year":"2022","unstructured":"Jhawar S, Arakawa Y, Kumar S, et al.. New insights on the genetics of pheochromocytoma and paraganglioma and its clinical implications. Cancers (Basel). 2022, 14:594. 10.3390\/cancers14030594","journal-title":"Cancers (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1530\/JME-22-0167","article-title":"Genetic bases of pheochromocytoma and paraganglioma","volume":"70","author":"Casc\u00f3n A","year":"2023","unstructured":"Casc\u00f3n A, Calsina B, Monteagudo M, Mellid S, D\u00edaz-Talavera A, Curr\u00e1s-Freixes M, Robledo M. Genetic bases of pheochromocytoma and paraganglioma. J Mol Endocrinol. 2023, 70:10.1530\/JME-22-0167","journal-title":"J Mol Endocrinol"},{"key":"ref6","article-title":"Hereditary paraganglioma-pheochromocytoma syndromes","author":"Else T","year":"2023","unstructured":"Else T, Greenberg S, Fishbein L. Hereditary paraganglioma-pheochromocytoma syndromes. GeneReviews. Adam MP, Feldman J, Mirzaa GM, et al. (ed): University of Washington, Seattle, WA; 2023."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2015.06.006","article-title":"Intergenerational epigenetic inheritance in models of developmental programming of adult disease","volume":"43","author":"Fernandez-Twinn DS","year":"2015","unstructured":"Fernandez-Twinn DS, Const\u00e2ncia M, Ozanne SE. Intergenerational epigenetic inheritance in models of developmental programming of adult disease. Semin Cell Dev Biol. 2015, 43:85-95. 10.1016\/j.semcdb.2015.06.006","journal-title":"Semin Cell Dev Biol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple endocrine tumors associated with germline Max mutations: multiple endocrine neoplasia type 5?","volume":"106","author":"Seabrook AJ","year":"2021","unstructured":"Seabrook AJ, Harris JE, Velosa SB, et al.. Multiple endocrine tumors associated with germline Max mutations: multiple endocrine neoplasia type 5?. J Clin Endocrinol Metab. 2021, 106:1163-82. 10.1210\/clinem\/dgaa957","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1442691","article-title":"Genotype and clinical phenotype characteristics of MAX germline mutation-associated pheochromocytoma\/paraganglioma syndrome","volume":"15","author":"Lian B","year":"2024","unstructured":"Lian B, Lu J, Fang X, et al.. Genotype and clinical phenotype characteristics of MAX germline mutation-associated pheochromocytoma\/paraganglioma syndrome. Front Endocrinol (Lausanne). 2024, 15:1442691. 10.3389\/fendo.2024.1442691","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa201","article-title":"Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precision medicine","volume":"29","author":"Casey R","year":"2020","unstructured":"Casey R, Neumann HP, Maher ER. Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precision medicine. Hum Mol Genet. 2020, 29:R128-37. 10.1093\/hmg\/ddaa201","journal-title":"Hum Mol Genet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Burnichon N","year":"2012","unstructured":"Burnichon N, Casc\u00f3n A, Schiavi F, et al.. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res. 2012, 18:2828-37. 10.1158\/1078-0432.CCR-12-0160","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0294","article-title":"Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: not a needle in a haystack","volume":"10","author":"Castro-Teles J","year":"2021","unstructured":"Castro-Teles J, Sousa-Pinto B, Rebelo S, Pignatelli D. Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: not a needle in a haystack. Endocr Connect. 2021, 10:R293-304. 10.1530\/EC-21-0294","journal-title":"Endocr Connect"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s13304-017-0451-y","article-title":"Surgical approaches in hereditary endocrine tumors","volume":"69","author":"Iacobone M","year":"2017","unstructured":"Iacobone M, Citton M, Viel G, Schiavone D, Torresan F. Surgical approaches in hereditary endocrine tumors. Updates Surg. 2017, 69:181-91. 10.1007\/s13304-017-0451-y","journal-title":"Updates Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.8898","article-title":"Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy","volume":"2","author":"Neumann HP","year":"2019","unstructured":"Neumann HP, Tsoy U, Bancos I, et al.. Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy. JAMA Netw Open. 2019, 2:e198898. 10.1001\/jamanetworkopen.2019.8898","journal-title":"JAMA Netw Open"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvae108","article-title":"PRAP study-partial versus radical adrenalectomy in hereditary pheochromocytomas","volume":"191","author":"Xu K","year":"2024","unstructured":"Xu K, Langenhuijsen JF, Vi\u00ebtor CL, et al.. PRAP study-partial versus radical adrenalectomy in hereditary pheochromocytomas. Eur J Endocrinol. 2024, 191:345-53. 10.1093\/ejendo\/lvae108","journal-title":"Eur J Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting S","year":"2022","unstructured":"N\u00f6lting S, Bechmann N, Taieb D, et al.. Personalized management of pheochromocytoma and paraganglioma. Endocr Rev. 2022, 43:199-239. 10.1210\/endrev\/bnab019","journal-title":"Endocr Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.609263","article-title":"Case report: Pheochromocytoma and synchronous neuroblastoma in a family with hereditary pheochromocytoma associated with a MAX deleterious variant","volume":"12","author":"Duarte DB","year":"2021","unstructured":"Duarte DB, Ferreira L, Santos AP, et al.. Case report: Pheochromocytoma and synchronous neuroblastoma in a family with hereditary pheochromocytoma associated with a MAX deleterious variant. Front Endocrinol (Lausanne). 2021, 12:609263. 10.3389\/fendo.2021.609263","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrad109","article-title":"Total adrenalectomy versus subtotal adrenalectomy for bilateral pheochromocytoma: meta-analysis","volume":"7","author":"Schiavone D","year":"2023","unstructured":"Schiavone D, Ballo M, Filardo M, Dughiero S, Torresan F, Rossi GP, Iacobone M. Total adrenalectomy versus subtotal adrenalectomy for bilateral pheochromocytoma: meta-analysis. BJS Open. 2023, 7:109. 10.1093\/bjsopen\/zrad109","journal-title":"BJS Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437562-pathogenic-max-variant-in-bilateral-adrenal-paragangliomas-the-dilemma-of-cortical-sparing-surgery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T10:05:59Z","timestamp":1763892359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437562-pathogenic-max-variant-in-bilateral-adrenal-paragangliomas-the-dilemma-of-cortical-sparing-surgery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.97541","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,23]]}}}